Beyond silencing - engineering applications of RNA interference and antisense technology for altering cellular phenotype

Current Opinion in Biotechnology

Volumn 19, Issue 5, 2008, Pages 500-505

  Hebert, Colin G ^a,b,c   Valdes, James J ^b   Bentley, William E ^a,c  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; APPLICATIONS; BIOTECHNOLOGY; MAMMALS; NUCLEIC ACIDS; PROTEINS; RNA;

ANTI-SENSE; ANTISENSE TECHNOLOGY; EMERGING APPLICATIONS; ENGINEERING APPLICATIONS; IN PLANTS; MAMMALIAN CELLS; METABOLIC ENGINEERING; NUTRITIONAL VALUES; RECOMBINANT PROTEIN PRODUCTIONS; RNA INTERFERENCE; TARGET PROTEINS;

ENGINEERING RESEARCH;

ANTIBIOTIC AGENT; RECOMBINANT PROTEIN;

ANTISENSE THERAPY; INSECT CELL; MAMMAL; METABOLIC ENGINEERING; NONHUMAN; NUTRITION; PHENOTYPE; PLANT BIOTECHNOLOGY; PRIORITY JOURNAL; PROKARYOTE; REVIEW; RNA INTERFERENCE;

BIOTECHNOLOGY; CELL PHYSIOLOGICAL PHENOMENA; GENE SILENCING; GENETIC ENGINEERING; METABOLOMICS; PHENOTYPE; RNA INTERFERENCE; RNA, ANTISENSE;

HEXAPODA; MAMMALIA;

EID: 53249134368     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2008.08.006     Document Type: Review

References (59)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
2. Tomari Y., and Zamore P.D. Perspective: machines for RNAi. Genes Dev 19 (2005) 517-529
3. Kumar L.D., and Clarke A.R. Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. Adv Drug Deliv Rev 59 (2007) 87-100
4. Echeverri C.J. High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet 7 (2006) 373-383
5. de Fougerolles A., Vornlocher H.P., Maraganore J., and Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6 (2007) 443-453
6. Dykxhoorn D.M., Palliser D., and Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Therapy 13 (2006) 541-552. Recent and comprehensive review of RNAi as a therapeutic. Discusses fundamentals, delivery technologies, and siRNA efficacy against specific diseases.
7. Bailey J.E. Toward a science of metabolic engineering. Science 252 (1991) 1668-1675
8. Stephanopoulos G., and Vallino J.J. Network rigidity and metabolic engineering in metabolite overproduction. Science 252 (1991) 1675-1681
9. Rao R.V., and Bredesen D.E. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol 16 (2004) 653-663
10. Majors B.S., Betenbaugh M.J., and Chiang G.G. Links between metabolism and apoptosis in mammalian cells: applications for anti-apoptosis engineering. Metab Eng 9 (2007) 317-326
11. ••].
12. Lai D.Z., Fu L., Weng S.J., Qi L.Q., Yu C.M., Yu T., Wang H.T., and Chen W. Blocking caspase-3 activity with a U6SnRNA promoter-driven ribozyme enhances survivability of CHO cells cultured in low serum medium and production of interferon-beta. Biotechnol Bioeng 85 (2004) 20-28
13. Lin C.C., Hsu J.T.A., Huang K.L., Tang H.K., Shu C.W., and Lai Y.K. Sf-Caspase-I-repressed stable cells: resistance to apoptosis and augmentation of recombinant protein production. Biotechnol Appl Biochem 48 (2007) 11-19
14. Kim E.J., Kramer S.F., Hebert C.G., Valdes J.J., and Bentley W.E. Metabolic engineering of the baculovirus expression system via inverse "shotgun" genomic analysis and RNA interference (dsRNA) increases product yield and cell longevity. Biotechnol Bioeng 98 (2007) 645-654
15. Gammell P., Barron N., Kumar N., and Clynes M. Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells. J Biotechnol 130 (2007) 213-218
16. March J.C., and Bentley W.E. Engineering eukaryotic signal transduction with RNAi: enhancing Drosophila S2 cell growth and recombinant protein synthesis via silencing of TSC1. Biotechnol Bioeng 95 (2006) 645-652
17. March J.C., and Bentley W.E. RNAi-based tuning of cell cycling in Drosophila S2 cells - effects on recombinant protein yield. Appl Microbiol Biotechnol 73 (2007) 1128-1135. The authors used dsRNA against several genes, including cycE (Cyclin E) and ago (Archipelago) to manipulate the cell cycle in Drosophila S2 cells, increasing the yield of recombinant protein. Furthermore, they demonstrated the importance of 'tuning' the level of RNAi suppression, because an intermediate level of cycE silencing resulted in the largest increase in protein production.
18. Hacker D.L., Bertschinger M., Baldi L., and Wurm F.M. Reduction of adenovirus E1A mRNA by RNAi results in enhanced recombinant protein expression in transiently transfected HEK293 cells. Gene 341 (2004) 227-234
19. Kuystermans D., Krampe B., Swiderek H., and Al-Rubeai M. Using cell engineering and omic tools for the improvement of cell culture processes. Cytotechnology 53 (2007) 3-22. Overview of current metabolic engineering strategies in cell culture, including RNAi screening and other omic technologies.
20. Mori K., Kuni-Karnochi R., Yarnane-Ohnuki N., Wakitani M., Yamano K., Imai H., Kanda Y., Niwa R., Iida S., Uchida K., et al. Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. Biotechnol Bioeng 88 (2004) 901-908
21. Kanda Y., Imai-Nishiya H., Kuni-Kamochi R., Mori K., Inoue M., Kitajima-Miyama K., Okazaki A., Iida S., Shitara K., and Satoh M. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: A new strategy for generating completely non-fucosylated recombinant therapeutics. J Biotechnol 130 (2007) 300-310
22. Imai-Nishiya H., Mori K., Inoue M., Wakitani M., Iida S., Shitara K., and Satoh M. Double knockdown of alpha 1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC. BMC Biotechnol (2007) 7
23. Ngantung F.A., Miller P.G., Brushett F.R., Tang G.L., and Wang D.I.C. RNA interference of sialidase improves glycoprotein sialic acid content consistency. Biotechnol Bioeng 95 (2006) 106-119
24. ••] that have used transcriptional profiling to identify metabolic engineering targets during the production cycle of HEK293 (Lee) or CHO (Wong) cells by identifying genes that are upregulated during periods of apoptosis. Potential targets have been successfully suppressed in CHO cells, leading to increased viability and recombinant protein production (Wong).
25. ••].
26. Rasmussen L.C.V., Sperling-Petersen H.U., and Mortensen K.K. Hitting bacteria at the heart of the central dogma: sequence-specific inhibition. Microb Cell Factories 6 (2007) 24. Comprehensive review of antisense technologies in bacteria. Gives more information on fundamental mechanisms, synthesis, and delivery than could be covered in this review.
27. Kemmer C., and Neubauer P. Antisense RNA based down-regulation of RNaseE in E. coli. Microb Cell Factories 5 (2006) 38
28. Tummala S.B., Junne S.G., and Papoutsakis E.T. Antisense RNA downregulation of coenzyme A transferase combined with alcohol-aldehyde dehydrogenase overexpression leads to predominantly alcohologenic Clostridium acetobutylicum fermentations. J Bacteriol 185 (2003) 3644-3653
29. Bouazzaoui K., and Lapointe G. Use of antisense RNA to modulate glycosyltransferase gene expression and exopolysaccharide molecular mass in Lactobacillus rhamnosus. J Microb Methods 65 (2006) 216-225
30. Sturino J.M., and Klaenhammer T.R. Engineered bacteriophage defense systems in bioprocessing. Nat Rev Microbiol 4 (2006) 395-404
31. Guerrier-Takada C., Li Y., and Altman S. Artificial regulation of gene expression in Escherichia coli by RNase P. Proc Natl Acad Sci U S A 92 (1995) 11115-11119
32. Soler Bistue A.J., Ha H., Sarno R., Don M., Zorreguieta A., and Tolmasky M.E. External guide sequences targeting the aac(6′)-lb mRNA induce inhibition of amikacin resistance. Antimicrob Agents Chemother 51 (2007) 1918-1925
33. McKinney J., Zhang H., Kubori T., Galan J.E., and Altman S. Disruption of type III secretion in Salmonella enterica serovar Typhimurium by external guide sequences. Nucleic Acids Res 32 (2004) 848-854
34. Sarno R., Ha H., Weinsetel N., and Tolmasky M.E. Inhibition of aminoglycoside 6′ N-acetyltransferase type Ib-mediated amikacin resistance by antisense oligonucleotides. Antimicrob Agents Chemother 47 (2003) 3296-3304
35. Geller B.L. Antibacterial antisense. Curr Opin Mol Ther 7 (2005) 109-113
36. Good L. Antisense antibacterials. Expert Opin Ther Patents 12 (2002) 1173-1179
37. Peterson L., de Koning M.C., van Kuik-Romeijn P., Weterings J., Pol C.J., Platenburg G., Overhand M., van der Maerl G.A., and van Boom J.H. Synthesis and in vitro evaluation of PNA-peptide-DETA conjugates as potential cell penetrating artificial ribonucleases. Bioconjug Chem 15 (2004) 576-582
38. Harth G., Zamecnik P.C., Tabatadza D., Pierson K., and Horwitz M.A. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 104 (2007) 7199-7204
39. Meng J.R., Hu B.Q., Liu J., Hou Z., Meng J., Jia M., and Luo X.X. Restoration of oxacillin susceptibility in methicillin-resistant Staphylococcus aureus by blocking the MecR1-mediated signaling pathway. J Chemother 18 (2006) 360-365
40. Tan X.X., Actor J.K., and Chen Y. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob Agents Chemother 49 (2005) 3203-3207
41. Kurupati P., Tan K.S., Kumarasinghe G., and Pol C.J. Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamase-producing Klebsiella pneummoniae strain. Antimicrob Agents Chemother 51 (2007) 805-811. Study demonstrating the potential use of antisense PNAs as a means of preventing infection in antibiotic resistant K. pneumoniae while maintaining the viability of IMR60 epithelial cells. One major issue that remains efficient delivery of PNAs across the cell membrane.
42. Nekhotiaeva N., Awasthi S.K., Nielsen P.E., and Good L. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol Ther 10 (2004) 625-629
43. Tilley L.D., Hine O.S., Kellogg J.A., Hassinger J.N., Weller D.D., Iversen P.L., and Geller B.L. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture. Antimicrob Agents Chemother 50 (2006) 2789-2796
44. Tilley L.D., Mellbye B.L., Puckett S.E., Iversen P.L., and Geller B.L. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli. J Antimicrob Chemother 59 (2007) 66-73
45. Warfield K.L., Panchal R.G., Aman M.J., and Bavari S. Antisense treatments for biothreat agents. Curr Opin Mol Ther 8 (2006) 93-103
46. Waterhouse P.M., Graham M.W., and Wang M.B. Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA. Proc Natl Acad Sci U S A 95 (1998) 13959-13964
47. Chuang C.F., and Meyerowitz E.M. Specific and heritable genetic interference by double-stranded RNA in Arabidopsis thaliana. Proc Natl Acad Sci U S A 97 (2000) 4985-4990
48. Smith N.A., Singh S.P., Wang M.B., Stoutjesdijk P.A., Green A.G., and Waterhouse P.M. Total silencing by intron-spliced hairpin RNAs. Nature 407 (2000) 319-320
49. Helliwell C.A., Wesley S.V., Wielopolska A.J., and Waterhouse P.M. High-throughput vectors for efficient gene silencing in plants. Funct Plant Biol 29 (2002) 1217-1225
50. Wielopolska A., Townley H., Moore I., Waterhouse P.M., and Helliwell C.A. A high-throughput inducible RNAi vector for plants. Plant Biotechnol J 3 (2005) 583-590
51. Tang G.L., Galili G., and Zhuang X. RNAi and microRNA: breakthrough technologies for the improvement of plant nutritional value and metabolic engineering. Metabolomics 3 (2007) 357-369. Recent review of RNAi and plant biotechnology. Provides more background, detail, and fundamental information than given in this review.
52. Houmard N.M., Mainville J.L., Bonin C.P., Haung S., Luethy M.H., and Malvar T.M. High-lysine corn generated by endosperm-specific suppression of lysine catabolism using RNAi. Plant Biotechnol J 5 (2007) 605-614
53. Segal G., Song R.T., and Messing J. A new opaque variant of maize by a single dominant RNA-interference-inducing transgene. Genetics 165 (2003) 387-397
54. Sunilkumar G., Campbell L.M., Puckhaber L., Stipanovic R.D., and Rathore K.S. Engineering cottonseed for use in human nutrition by tissue-specific reduction of toxic gossypol. Proc Natl Acad Sci U S A 103 (2006) 18054-18059. The authors used a seed-specific promoter to reduce the toxicity of cottonseed and its oil by suppressing δ-cadinene synthase. Expression was not affected in other tissues, maintaining cotton's natural defense abilities. Although field tests and regulatory hurdles remain, this potentially opens up a novel food source for many people throughout the world.
55. Regina A., Bird A., Topping D., Bowden S., Freeman J., Barsby T., Kosar-Hashemi B., Li Z., Rahman S., and Morell M. High-amylose wheat generated by RNAi interference improves indices of large-bowel health in rats. Proc Natl Acad Sci U S A 103 (2006) 3546-3551
56. Dodo H.W., Konan K.N., Chen F.C., Egnin M., and Viquez O.M. Alleviating peanut allergy using genetic engineering: the silencing of the immunodominant allergen Ara h 2 leads to its significant reduction and a decrease in peanut allergenicity. Plant Biotechnol J 6 (2008) 135-145
57. Allen R.S., Miller J.A.C., Chitty J.A., Fist A.J., Gerlach W.L., and Larkin P.J. Metabolic engineering of morphinan alkaloids by over-expression and RNAi suppression of salutaridinol 7-O-acetyltransferase in opium poppy. Plant Biotechnol J 6 (2008) 22-30
58. Qiao F., Yang Q., Wang C.L., Fan Y.L., Wu X.F., and Zhao K.J. Modification of plant height via RNAi suppression of OsGA20ox2 gene in rice. Euphytica 158 (2007) 35-45
59. Dykxhoorn D.M., and Lieberman J. The silent revolution: RNA interference as a basic biology, research tool, and therapeutic. Annu Rev Med 56 (2005) 401-423